Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eaton Vance Ohio Municipal Income Trust
(NQ:
EVO
)
3.350
+0.260 (+8.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eaton Vance Ohio Municipal Income Trust
< Previous
1
2
3
4
Next >
Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths
August 13, 2024
Via
ACCESSWIRE
Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
August 12, 2024
Via
ACCESSWIRE
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
August 07, 2024
Via
ACCESSWIRE
Evotec SE Reports First Half-year 2024 Results on 14 August 2024
August 07, 2024
Via
ACCESSWIRE
Evotec SE Provides Guidance Update
August 06, 2024
Via
ACCESSWIRE
Evotec Provides Guidance Update
August 06, 2024
Via
ACCESSWIRE
Evotec and Pfizer Collaborate to Advance Drug Discovery in France
July 09, 2024
Via
ACCESSWIRE
Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
July 08, 2024
Via
ACCESSWIRE
Evotec Reports Q1 2024 Results and Provides Corporate Update
May 21, 2024
Via
ACCESSWIRE
Evotec SE: Invitation to Conference Call
January 21, 2024
Via
ACCESSWIRE
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
June 24, 2024
Via
ACCESSWIRE
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
June 12, 2024
Via
ACCESSWIRE
Evotec SE: Results of the Annual General Meeting 2024
June 10, 2024
Via
ACCESSWIRE
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
May 29, 2024
Via
ACCESSWIRE
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
May 27, 2024
Via
ACCESSWIRE
Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
May 15, 2024
Via
ACCESSWIRE
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
May 14, 2024
From
Centogene NV
Via
GlobeNewswire
Bayer and Evotec Collaborate to Advance Precision Cardiology
April 29, 2024
Via
ACCESSWIRE
Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth
April 23, 2024
Via
ACCESSWIRE
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
April 23, 2024
Via
ACCESSWIRE
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
April 18, 2024
Via
ACCESSWIRE
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
April 17, 2024
Via
ACCESSWIRE
Evotec welcomes Aurélie Dalbiez as Chief People Officer
April 16, 2024
Via
ACCESSWIRE
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
March 05, 2024
Via
ACCESSWIRE
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
February 06, 2024
Via
ACCESSWIRE
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
January 10, 2024
Via
ACCESSWIRE
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
January 07, 2024
Via
ACCESSWIRE
Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
January 03, 2024
Via
ACCESSWIRE
Evotec Announces CEO Transition
January 03, 2024
Via
ACCESSWIRE
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
December 18, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.